ArticleSovremennye tekhnologii v meditsine2026
The Capabilities of Multimodal Magnetic Resonance Morphometry to Diagnose Complex Cases of Focal Cortical Dysplasia (Pilot Study).
Article in Sovremennye tekhnologii v meditsine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Focal cortical dysplasia (FCD) is a leading cause of pharmacoresistant epilepsy. Up to 30-50% of cases remain MRI-negative on routine visual assessment. MR morphometry improves dysplasia detection; however, conventional approaches are limited to the analysis of T1-weighted images and only two features (gray-white matter blurring and cortical thickness abnormalities). Materials and Methods: The study included four patients with histologically verified FCD (2 patients with type I and 2 patients with type IIB according to the Blümcke classification). All patients underwent MRI using the HARNESS protocol. MR morphometry was performed using two independent algorithms.The conventional method included FreeSurfer-based assessment of 2 features (the analysis of cortical thickening and gray-white matter boundary blurring) on T1-weighted images.The multimodal morphometric algorithm incorporated T1/T2-weighted images and FLAIR, and included the following features: gray-white matter transition abnormalities on T1, T2, and T2-FLAIR images (Blurring_T1/T2/FLAIR); detection of local T2- and FLAIR-hyperintense signal abnormalities (CR_T2/FLAIR); assessment of FLAIR intensity distribution heterogeneity to identify blurred boundaries or the transmantle sign (Variance); measurement of signal irregularity on FLAIR images to detect the regions of increased contrast (Entropy). Machine learning models integrating all extracted features were used to generate final FCD prediction maps (MLP and XGBoost). Results: In two cases, where FCD had typical T1-signs (cortical thickening or well-defined demarcation impairment), both algorithms demonstrated equal diagnostic performance. In the third case, the classical approach failed to detect pathology, since only T1-weighted images were analyzed, whereas the multimodal approach enabled to identify dysplastic areas (only T2/FLAIR images showed the changes). In the fourth case, the conventional algorithm detected a single lesion, while the multimodal algorithm identified an additional second lesion, which influenced the surgical treatment strategy. Conclusion: Multimodal MR morphometry with artificial intelligence outperforms the conventional approach in complex cases (MRI-negative and multifocal lesions) and should be considered an important supplementary technique in preoperative planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.